Table 3. 30-day perioperative data of patients with aortic diseases.
| Variable | AAA (F1, %) | TAA (F2, %) | Type A AD (F3, %) | Type B AD (F4, %) | Ptotal |
| Procedure-related complications | 6.41±0.49 (64/999) | 2.44±1.09 (2/82) | 4 (1/25) | 13.96±0.81 (255/1826) | 0.000<0.01 |
| Overall neurologic complications | 0.31±0.04 (3/980) | 4.50±0.91 (5/111) | 6.67±0.00 (2/30) | 1.66±0.03 (53/3202) | 0.000<0.01 |
| Stroke | 0.11±0.02 (1/938) | 1.96±0.43 (2/102) | 6.67±0.00 (2/30) | 0.82±0.02 (25/3052) | 0.002<0.01 |
| Paraplegia | 0.20±0.03 (2/1021) | 0 (0/113) | 0 (0/47) | 0.06±0.01 (2/3540) | 0.630 |
| Post-procedural endoleak | 10.08±0.52 (110/1091) | 19.27±5.74 (21/109) | 19.15±1.50 (9/47) | 9.39±0.25 (342/3642) | 0.004<0.01 |
| Cardiac complications | 0.95±0.09 (9/948) | 1.22±0.55 (1/82) | 10.34±2.44 (3/29) | 1.76±0.14 (16/908) | 0.025<0.05 |
| Renal complications | 1.12±0.17 (10/893) | 2.44±1.09 (2/82) | 13.79±4.88 (4/29) | 2.91±0.15 (43/1476) | 0.001<0.01 |
| Pulmonary complications | 0.77±0.08 (7/906) | 0 (0/82) | 10.34±2.44 (3/29) | 1.64±0.12 (15/916) | 0.005<0.01 |
| Visceral complications | 0.92±0.10 (8/868) | 0 (0/82) | 10.34±2.44 (3/29) | 2.78±0.43 (22/791) | 0.001<0.01 |
| 30-day mortality | 2.44±0.20 (27/1105) | 3.54±0.62 (4/113) | 7.69±1.67 (6/78) | 2.36±0.04 (89/3770) | 0.023*<0.05 |
| Aorta-related mortality | 0.47±0.04 (5/1062) | 0.98±0.33 (1/102) | 1.28±0.02 (1/78) | 0.83±0.02 (27/3269) | 0.607 |
| Non-aorta related mortality | 1.89±0.20 (20/1062) | 2.94±0.69 (3/102) | 6.41±1.57 (5/78) | 1.53±0.04 (50/3259) | 0.008<0.01 |
Procedure-related complications: F2<F4 (P = 0.003); No significant differences in other two-group comparisons. Overall neurologic complications: F1<F2 (P = 0.000); F1<F3 (P = 0.008); F1<F4 (P = 0.001); No significant differences in other two-group comparisons. Stroke: F1<F2 (P = 0.027); F1<F3 (P = 0.003); F1<F4 (P = 0.018); F3>F4 (P = 0.028); No significant differences in other two-group comparisons. Post-procedural endoleak: F1<F2 (P = 0.003); F1<F3 (P = 0.047); F2>F4 (P = 0.001); F3>F4 (P = 0.044); No significant differences in other two-group comparisons. Cardiac complications: F1<F3 (P = 0.000); F2>F3 (P = 0.000); F3>F4 (P = 0.019); No significant differences in other two-group comparisons. Renal complications: F1<F3 (P = 0.000); F1<F4 (P = 0.004); F2<F3 (P = 0.005); F3>F4 (P = 0.011); No significant differences in other two-group comparisons. Pulmonary complications: F1<F3 (P = 0.000); F2<F3 (P = 0.016); F3>F4 (P = 0.016); No significant differences in other two-group comparisons. Visceral complications: F1<F3 (P = 0.000); F2<F3 (P = 0.016); No significant differences in other two-group comparisons. 30-day mortality: F1<F3 (P = 0.018); F3>F4 (P = 0.003); No significant differences in other two-group comparisons. Aorta-related mortality: F1<F3 (P = 0.025); F3>F4 (P = 0.004); No significant differences in other two-group comparisons (*Log rank test).